Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S0106B, Stem Cell Origin in AML: Prognostic and Therapeutic Implications

NCT01575535 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT01575535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01575535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S0106B, Stem Cell Origin in AML: Prognostic and Therapeutic Implications
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
May 31, 2012
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia